Clinical Trials
5 trialsNCT04290546 2026-02-27
CIML NK Cell in Head & Neck Cancer
Dana-Farber Cancer Institute
Phase 1 Completed
NCT04417465 2025-09-25
First In Human Study With ABBV-CLS-579 When Given Alone and In Combination In Participants With Locally Advanced Or Metastatic Tumors
AbbVie
Phase 1 Completed
NCT04944888 2023-12-19
GSL Synthetase Inhibitor in Combination With Immune Checkpoint Inhibitor in Previously Treated Blood and Solid Tumor
Chinese PLA General Hospital
Phase 1 Completed
NCT03790488 2023-07-03
Study of a PD-1 Inhibitor (JTX-4014) in Subjects With Solid Tumor Malignancies
Jounce Therapeutics, Inc.
Phase 1 Completed
NCT02574533 2017-09-27
Pilot Study of Vigilâ„¢ + Pembrolizumab for Advanced Melanoma
Gradalis, Inc.
Phase 1 Completed